INTRODUCTION AND OBJECTIVES: Testicular sperm extraction (TESE) is successful in identifying a small number of sperm in 50% of men with non-obstructive azoospermia (NOA). Traditionally, sperm are isolated from testicular tissue using a combination of standard light microscopy, tissue digestion and time analyzing the specimen in hope to isolate rare spermatozoa. Here we discuss our results utilizing fluorescence-activated cell sorting (FACS) of testis tissue to increase the efficiency in the isolation of spermatozoa.
METHODS: Testicular tissue was obtained from 10 patients: 2 cadaveric specimens with normal spermatogenesis and 8 specimens from wasted testicular tissue from microTESE. The specimens were prepared by sharp cutting followed by mechanical disaggregation with a Medimachine (BD Biosciences, USA) and passed through a 50-and 30micron filter. The specimens were then stained with DNA-stains To-Pro-3 or SYTO 17(ThermoFischer, USA) and incubated. Sperm from a normal semen sample were stained similarly and used as controls for gating during flow cytometry . Then, cell sorting was completed using a FACSAria II (BD Biosciences, USA) to isolate spermatozoa. Each sorted specimen underwent standard light microscopy to identify spermatozoa.
RESULTS: Using this technique, spermatozoa were successfully isolated and recovered in both cadaveric specimens. Of the 8 patients undergoing microTESE , 3 (38%) had spermatozoa recovered using standard tissue processing and 4 (50%) had spermatozoa recovered using FACS. Notably, in our cohort, both patients with maturation arrest had a negative microTESE with standard tissue processing, but had successful isolation of spermatozoa using FACS. CONCLUSIONS: Our initial experience using fluorescenceactivated cell sorting for rare spermatozoa isolation from testicular tissue proves the technical feasibility of this process. As this research continues to be refined and implemented, the clinical application of this technique has the potential to increase the rate of successful TESE to isolate spermatozoa.
Source of Funding: None

PD68-02 SPERM EXTRACTION LOCATION CAN AFFECT EARLY EMBRYO MORPHOKINETICS
Nicholas Tadros*, Pavinder Gill, Edmund Sabanegh, Nina Desai, Cleveland, OH INTRODUCTION AND OBJECTIVES: The sperm centrosome plays an important role in early embryo development. Paternal effect on embryonic cleavage and blastocyst formation can be affected in cases of severe male infertility where spermatogenesis is abnormal. We compared morphokinetics of embryonic development in patient embryos created from sperm extracted from the testis and epididymis.
METHODS: The charts of 72 men with severe oligospermia or azoospermia who underwent successful IVF/ICSI were retrospectively reviewed. Demographics, endocrine labs, semen analysis, genetic testing data, pathologic diagnosis and location of sperm extraction were analyzed. Zygotes were cultured in the Embryscope time lapse imaging chamber. Kinetic data and cycle outcome data were analyzed. Clinical pregnancy rate (CPR), implantation rate (IR) and blastulation rate were calculated.
RESULTS: 41 men (56.9%) underwent sperm extraction from the testis with 28 (68.3%) having a microTESE. 31 men (43.1%) had epididymal sperm extraction, with the 74.2% having a percutaneous extraction. The most common diagnosis in the epididymal group was presence of vasectomy (61.3%) and idiopathic nonobstructive azoospermia (63.4%) in the testicular group. The average FSH (mU/mL) in the epididymal group was 3.8 and was 17.6 in the testicular group (p ¼ 0.051). There was no difference in LH (p ¼ 0.88), testosterone (p ¼ 0.46) or estradiol (0.725) between the two groups. CPR and IR in the testicular sperm group (51% and 31%, respectively) was similar to that of the epididymal group (57% and 37%, respectively). Embryos in the testicular sperm group were significantly slower in reaching early kinetic endpoints (t2,t4,t8), though tM, tSB and tEBL from both groups were similar. The mean day 3 embryo cell count was lower with testicular (7.69 +/-2.09) vs epididymal derived (8.65 +/-2.73; p¼0.03) embryos. There was an increased percentage of embryos in the testicular group that failed to compact (TESE 31%,vs PESA 16%; P<0.0001).
CONCLUSIONS: Delayed developmental times were observed in embryos derived from testicular sperm up until the stage of compaction (an early indicator of embryonic genomic activation). Embryos from the testicular group arrested at a higher rate prior to this stage but after this stage, they had similar kinetics as epididymal derived embryos. Larger, prospective studies examining sperm quality in testicular extraction patients and its relationship to embryo kinetics may help to further elucidate these results. is an important treatment option for men with non-obstructive azoospermia (NOA). Although men with NOA have 0% normal forms, laboratory staff will commonly avoid ICSI of individual sperm because of subjective considerations of sperm 00 quality 00 based on morphologic evaluation. We report the effect of injected sperm characteristics on fertilization and pregnancy rates in ICSI following microTESE in men with NOA.
Source of
METHODS: We conducted a retrospective review of all men at a single institution who had successful sperm retrieval at microTESE and then proceeded to ICSI between 05/13 and 06/16. Information was collected on demographics, injected sperm characteristics at ICSI, fertilization, and pregnancy rates. Comparisons were done using Fisher 0 s test, gamma test, one-way ANOVA, and multivariable analysis (MVA), with significance set at p<0.05. Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1339 RESULTS: A total of 198 men (mean age 35AE8 years) were included. Fertilization and pregnancy rates were 44% and 38%, respectively. On univariable analysis, sperm motility and the lack of acrosome defects were associated with higher fertilization and pregnancy rates while an increasing number of total sperm abnormalities was negatively associated with fertilization, but not pregnancy, rates (Table) . On MVA, only sperm motility was associated with fertilization rates (p<0.001) while both sperm motility (p¼0.004) and the lack of acrosome abnormalities (p¼0.018) were associated with pregnancy rates. Female age (mean age 31AE5 years) was not associated with fertilization or pregnancy rates on MVA.
CONCLUSIONS: This study is the first to assess the relationship between injected testicular sperm characteristics and reproductive outcomes in ICSI. All men with NOA have abnormal sperm morphology and our experience suggests that no specific sperm abnormality, including injection of non-motile sperm, precludes the chance of pregnancy. Further study of sperm characteristics may influence how aggressively surgeons should seek better sperm quality during micro-TESE procedures. Use of elongating spermatids (blunt-tailed sperm) did not adversely affect the chance of pregnancy despite concerns for lower fertilization with severely blunt-tailed sperm.
Source of Funding: Supported by The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust.
PD68-04
IMPACT OF CFTR MUTATIONS ON PHENOTYPE AND REPRODUCTIVE OUTCOMES IN MEN WITH CONGENITAL ABSENCE OF THE VAS DEFERENS
Phil V. Bach*, New York, NY; Filipe Neto, Recife, Brazil; Bobby Najari, Ryan Flannigan, Miriam Feliciano, Philip Li, Marc Goldstein, New York, NY INTRODUCTION AND OBJECTIVES: Congenital absence of vas deferens (CAVD) causes obstructive azoospermia in 1% of infertile men and can be treated using epididymal sperm aspiration (MESA) coupled with intracytoplasmic sperm injection (IVF/ICSI). CAVD can be seen in patients with and without mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. There is an ongoing debate about whether CFTR mutations affect spermatogenesis. We hypothesized that CFTR mutations in men with CAVD would negatively affect reproductive outcomes.
METHODS: We retrospectively reviewed a database of 78 infertile men with CAVD who were treated by a single surgeon from 1990 to 2016. Information on demographics, phenotype, CFTR mutations, and IVF/ICSI outcomes were collected. Patients with CFTR mutations (CFTR+) and without CFTR mutations (CFTR-) were compared using Fisher test and unpaired t-test, with significance set at p<0.05.
RESULTS: We identified 65 men with CAVD who were screened for CFTR mutations, of whom 34 had bilateral CAVD and underwent MESA and IVF/ICSI at our institution. Average patient and partner ages were 33AE6 years and 31AE5 years, respectively. 36 patients (55%) were CFTR+ while 29 patients (45%) were CFTR-. 92% of CFTR+ patients presented with bilateral CAVD compared to 79% of . Renal anomalies were only seen in CFTR-patients (Table) . Amongst CFTRpatients, 50% with unilateral CAVD and 35% with bilateral CAVD had renal anomalies (p¼0.65). The most common CFTR mutation detected was Df508 (50%), followed by w1882x (22%) and 5t (17%). 24 CFTR+ couples underwent 47 IVF/ICSI cycles and 10 CFTR-couples underwent 13 IVF/ ICSI cycles. While fertilization rates were higher in CFTR-patients, there was no difference in clinical pregnancy or live birth rates (Table) .
CONCLUSIONS: Men with CAVD present evenly with and without CFTR mutations. CFTR-patients are more likely to harbor renal anomalies and should be screened while CFTR+ patients do not need to be screened for renal anomalies. While CFTR mutations negatively affect fertilization rates, there was no difference in clinical pregnancy or live birth rates after IVF/ICSI. Further studies with larger populations that examine the relationship between specific CFTR mutations and reproductive outcomes are warranted to substantiate our findings. INTRODUCTION AND OBJECTIVES: Non-iatrogenic, nontraumatic obstructive azoospermia (OA) includes causes like congenital bilateral absence of vas deferens (CBAVD), blockage at rete testis, or obstruction distal to internal inguinal rings. The blockage could be potentially identified at scrotal exploration and corrected with vasoepididymostomy (VE). The purpose of this study is to analyze patients with non-iatrogenic, non-traumatic OA who underwent scrotal exploration with or without VE anastomosis in our institution.
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